ArticleAntioxidants (Basel, Switzerland)2021

MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer's Disease: A Study in Senescence-Accelerated OXYS Rats.

Natalia A Muraleva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.